Holen Sie sich die Stockscreener-App
1.07
3.88%
0.04
Schlusskurs vom Vortag:
$1.03
Offen:
$1.05
24-Stunden-Volumen:
162.93K
Relative Volume:
0.32
Marktkapitalisierung:
$104.81M
Einnahmen:
$13.56M
Nettoeinkommen (Verlust:
$-35.57M
KGV:
-2.4056
EPS:
-0.4448
Netto-Cashflow:
$-29.13M
1W Leistung:
-6.96%
1M Leistung:
+0.00%
6M Leistung:
-26.21%
1J Leistung:
+49.38%
1-Tages-Spanne:
$1.05
$1.096
1-Wochen-Bereich:
$1.03
$1.21
52-Wochen-Spanne:
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Firmenname
Hyperfine Inc
Sektor
Branche
Telefon
866-796-6767
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.07 | 100.90M | 13.56M | -35.57M | -29.13M | -0.4448 |
ABT
Abbott Laboratories
|
102.60 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.25 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.75 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.40 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.09 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2022-04-14 | Eingeleitet | Wells Fargo | Overweight |
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Inflation Data: Is Hyperfine Inc affected by consumer sentimentMarket Weekly Review & Daily Price Action Insights - baoquankhu1.vn
Aug Action: Is Hyperfine Inc stock showing strong momentumProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn
Hyperfine’s Portable MRI Trial Update Puts Contrast Imaging in the Spotlight - TipRanks
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Benzinga
Hyperfine (HYPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Sahm
Thomas Teisseyre Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock - MarketBeat
Hyperfine COO Teisseyre sells $29k in shares By Investing.com - in.investing.com
Hyperfine COO Teisseyre sells $29k in shares - Investing.com
Hyperfine (HYPR) COO sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) CFO Brett Hale sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) Q4 2025 Earnings Call Transcript - AOL.com
Hyperfine: $40 Million Loan Facility Secured To Expand Portable MRI Commercialization - pulse2.com
Growth Review: Is Hyperfine Inc a play on infrastructure spendingGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
Aug Update: How does Hyperfine Inc score in quality rankingsWeekly Trend Summary & Technical Confirmation Alerts - baoquankhu1.vn
Hyperfine Inc stock gains momentum on FDA clearance for Swoop portable MRI system expansion - AD HOC NEWS
Horizon Technology Finance extends USD 40M loan facility to Hyperfine - Medical Buyer
Hyperfine receives $40m from Horizon for Swoop System expansion - Yahoo Finance
Horizon Technology Finance provides $40M loan to Hyperfine By Investing.com - Investing.com South Africa
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine - 01net
Horizon Technology Finance Corporation Provides $40 Million Loan Facility to Hyperfine, Inc - marketscreener.com
Horizon Technology Finance provides $40M loan to Hyperfine - Investing.com
Horizon Technology Finance provides $40 million loan facility to Hyperfine - marketscreener.com
If You Invested $1,000 in HYPERFINE (HYPR) - Stock Titan
Published on: 2026-03-22 05:09:43 - baoquankhu1.vn
Published on: 2026-03-22 02:20:43 - baoquankhu1.vn
Hyperfine, Inc. (NASDAQ:HYPR) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Hyperfine (NASDAQ:HYPR) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Hyperfine Inc. Exposed to Rising Credit Risk as Delayed Customer Payments Threaten Cash Flow and Financial Stability - The Globe and Mail
Hyperfine Inc. Earnings Call Signals Commercial Breakthrough - The Globe and Mail
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript - insidermonkey.com
Market Wrap: Is Hyperfine Inc gaining market shareWeekly Trade Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
Lake Street Capital Issues Positive Forecast for Hyperfine (NASDAQ:HYPR) Stock Price - Defense World
Hyperfine (HYPR) Q4 Loss Improvement Tests Bullish Margin Narrative - simplywall.st
Lake Street raises Hyperfine stock price target on revenue growth outlook - Investing.com Australia
Lake Street Raises Price Target for Hyperfine (HYPR) as Buy Rati - gurufocus.com
Hyperfine Secures $40 Million Term Loan Financing Agreement - The Globe and Mail
Lake Street Capital Forecasts Strong Price Appreciation for Hyperfine (NASDAQ:HYPR) Stock - MarketBeat
Hyperfine Q4 2025 Financial Results & Swoop System Growth | March 2026News and Statistics - IndexBox
Lake Street raises Hyperfine stock price target on revenue growth outlook By Investing.com - Investing.com South Africa
Hyperfine (HYPR) Q4 2025 Financial Results Conference Call Transcript - Bitget
Guilford medtech firm secures up to $40M in debt financing - Hartford Business Journal
Hyperfine, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
B. Riley Raises Price Target on Hyperfine to $1.60 From $1.30, Keeps Buy Rating - marketscreener.com
Hyperfine reports net loss of USD 5.91M in Q4 2025 - medicalbuyer.co.in
Hyperfine Q4 2025 Earnings Call Transcript - MarketBeat
Hyperfine Reports Strong 2025 Growth, Launches Next-Gen Swoop MRI and Optive AI, Projects 55% Revenue Increase for 2026 - Minichart
Hyperfine Inc (HYPR) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Investing.com Canada
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - The National Law Review
Hyperfine outlines 55% revenue growth target for 2026 while expanding Swoop MRI adoption across hospitals and neurology offices - MSN
Earnings call transcript: Hyperfine Q4 2025 beats expectations, stock rises By Investing.com - Investing.com South Africa
Finanzdaten der Hyperfine Inc-Aktie (HYPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hyperfine Inc-Aktie (HYPR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HALE BRETT | CFO and CAO |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
275,812 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 13 '26 |
Sale |
1.11 |
821 |
913 |
378,836 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 19 '25 |
Sale |
1.08 |
1,405 |
1,517 |
379,657 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 18 '25 |
Sale |
1.33 |
1,151 |
1,531 |
381,062 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 16 '25 |
Sale |
0.58 |
2,776 |
1,610 |
82,213 |
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):